BRCA1 and posterior cortical atrophy: These cases, comprising 15–20% of all patients, are best described with the term “family-associated PCa” and should not be confused with hereditary PCa, which occurs less frequently, at an estimated 5% [33], and includes a population with a specific molecular profile—for instance, BRCA1/2 or HOXB13 mutation carriers [32].